Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint research program to create an AI-based pathology diagnostic tool at the 20th annual ...

A new study that analyzed protein levels in 2,002 primary tumors from 14 tissue-based cancer types identified 11 distinct molecular subtypes, providing systematic knowledge that greatly expands a ...

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model that is capable of performing an array of diagnostic tasks across multiple forms of cancers. The researchers, ...

CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biology company with a mission to transform drug development and clinical treatment decisions by unlocking the power of pathology data, today ...